| (210) | Number of the EPO application | 19889873 |
| (220) | Filing date of the EPO application | 2019.11.27 |
| (80) | EPO patent specification publication (B) | EPB nr. 15/2023, 2023.04.12 |
| (110) | EPO patent number | 3886820 |
| (11) | Number of the document | MD 3886820 T2 |
| (21) | Number of the application | e 2021 0972 |
| (71) | Name(s) of applicant(s), code of the country | ChemoCentryx, Inc., US; |
| (72) | Name(s) of inventor(s), code of the country | LELETI Manmohan Reddy, US;
POWERS Jay P., US; |
| (73) | Name(s) of owner(s), code of the country | ChemoCentryx, Inc., US; |
| (54) | Title of the invention | Capsule formulations |
| (13) | Kind-of-document code | T2 |
| (51) | International Patent Classification | A61K 9/48 (2006.01.01); A61K 31/451 (2006.01.01); A61K 47/10 (2006.01.01); A61K 47/14 (2006.01.01); A61K 47/40 (2006.01.01); A61K 47/44 (2006.01.01) |
| (19) | Country | US |
| (41) | Date of publication of the application | 2021.11.30 |
| (49) | Date of publication of the translation of the validated European patent specification | 2023.07.31 |
| (30) | Priority | 201862773848 P, 2018.11.30, US |
| (74) | Patent attorney | (Procedură) LAZICOV Tatiana, str. A. Pușkin nr. 33, ap. 73, MD-2012, Chișinau, Republica Moldova |
| (86) | International application | PCT/US2019/063547, 2019.11.27 |
| (87) | International publication | WO 2020/112961, 2020.06.04 |